134 related articles for article (PubMed ID: 6945906)
1. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.
Bennett JM; Begg CB
Cancer Res; 1981 Nov; 41(11 Pt 2):4833-7. PubMed ID: 6945906
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
Kurrle E; Hoelzer D; Heimpel H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
[TBL] [Abstract][Full Text] [Related]
3. Absence of the influence of age on remission rate and duration of remission in a group of thirty-four patients with acute myeloid leukaemia.
De Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H; De Vries-Hospers HG
Neth J Med; 1980; 23(6):241-5. PubMed ID: 6936611
[No Abstract] [Full Text] [Related]
4. [The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
Cavalli F; Sauter C; Senn HJ; Alberto P
Schweiz Med Wochenschr; 1976 Sep; 106(38):1265-8. PubMed ID: 1070154
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of acute leukaemia in adults.
Penington DG; Keating MJ
Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
[No Abstract] [Full Text] [Related]
6. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
7. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of acute leukemia. Results of the Swiss study group for clinical cancer research (SAKK)].
Obrecht JP; Alberto P; Brunner KW; Martz G; Nagel G; Senn HJ
Schweiz Med Wochenschr; 1974 Jan; 104(4):151. PubMed ID: 4521302
[No Abstract] [Full Text] [Related]
10. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
11. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute myeloid leukemia].
Obrecht JP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):190-200. PubMed ID: 6208102
[No Abstract] [Full Text] [Related]
13. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
[TBL] [Abstract][Full Text] [Related]
14. [Acute promyelocytic leukemia. Review of the literature].
Virgolini L
Minerva Med; 1984 Jul; 75(30-31):1797-802. PubMed ID: 6090991
[TBL] [Abstract][Full Text] [Related]
15. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
[TBL] [Abstract][Full Text] [Related]
16. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia in the adult.
di Cato MA
Bull Soc Sci Med Grand Duche Luxemb; 1975 Nov; 112(2):129-33. PubMed ID: 1060522
[No Abstract] [Full Text] [Related]
18. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
[TBL] [Abstract][Full Text] [Related]
19. [Morphological classification of acute myeloid leukemias using the FAB system. Retrospective analysis of 106 cases].
Reiffers J; Dachary D; Bernard P; Veyret V; Boisseau MR; Broustet A
Nouv Rev Fr Hematol (1978); 1982; 24(4):237-40. PubMed ID: 6959074
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
Petersdorf SH; Rankin C; Head DR; Terebelo HR; Willman CL; Balcerzak SP; Karnad AB; Dakhil SR; Appelbaum FR
Am J Hematol; 2007 Dec; 82(12):1056-62. PubMed ID: 17696203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
